Cost considerations for whole-body MRI and PET/CT as part of oncologic staging;Kostenüberlegungen zur ganzkörper-MRT und PET-CT im rahmen des onkologischen stagings

Radiologe

Volumn 48, Issue 4, 2008, Pages 384-396

  Plathow, C ^a,b   Walz, M ^c   Lichy, M P ^a   Aschoff, P ^a   Pfannenberg, C ^a   Bock, H ^a   Eschmann, S M ^a,d   Claussen, C D ^a   Schlemmer, H P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c TÜV Industrie Service GmbH TÜV SÜD Group   (Germany)

^d MARIENHOSPITAL STUTTGART   (Germany)

Author keywords

Cost effectiveness; Magnetic resonance imaging (MRI); Oncology; Positron emission tomography computed tomography (PET CT); Staging

Indexed keywords

ARTICLE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ENDOSCOPIC ECHOGRAPHY; HEALTH CARE COST; HUMAN; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; WHOLE BODY MRI;

DIAGNOSIS-RELATED GROUPS; GERMANY; HEALTH CARE COSTS; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 44249083271     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-007-1547-z     Document Type: Article

References (41)

1. Schlemmer HP, Schaefer J, Pfannenberg C et al. (2005) Fast whole-body assessment of metastatic disease using a novel magnetic resonance imaging system. Invest Radiol 40: 64-71
2. Schmidt GP, Haug AR, Schoenberg SO, Reiser MF (2006) Whole-body MRI and PET-CT in the management of cancer patients. Eur Radiol 16: 1216-1225
3. Schafer JF, Schlemmer HP (2006) Total-body MR imaging in oncology. Eur Radiol 16: 2000-2015
4. Muller-Horvat C, Radny P, Eigentler TK et al. (2006) Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer 42: 342-350
5. Steidle G, Schafer J, Schlemmer HP et al. (2004) Two-dimensional parallel acquisition technique in 3D MR colonography. Rofo 176: 1100-1105
6. Eustace S, Tello R, DeCarvalho V et al. (1997) A comparison of whole body TurboSTIR MT imaging and planar 99mTC-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169: 1655-1661
7. Ruehm S, Goyen M, Quick H et al. (2000) Ganzkörper-MRA auf einer rollenden Tischplattform (AngioSurf). Rofo 172: 670-574
8. Barkhausen J, Quick HH, Lauenstein T et al. (2001) Whole-body MR imaging in 30 seconds with real-time trueFISP and a continuously rolling table platform: feasibility and study. Radiology 220: 252-256
9. Walker RE, Eustace SJ (2001) Whole-body magnetic resonance imaging: techniques, clinical indications, and future applications. Semin Musculoskelet Radiol 5: 5-20
10. Fenchel M, Requardt M, Tomaschko K et al. (2005) Whole-body MR angiography using 32-receiving-channel MR system with surface coil technology: first clinical experience. J Magn Reson Imaging 21: 596-603
11. Quick HH, Vogt FM, Maderwald S et al. (2004) High spatial resolution whole-body MR angiography featuring parallel imaging: initial experience. Rofo 176: 163-169
12. Mijnhout GS, Hoekstra OS, van Tulder MW et al. (2001) Systemic review of the diagnsotic accuracy of 18F-fluorodeoxyglucose positron emission tomography in melanoma patients. Cancer 91: 1530-1542
13. Eschmann SM, Blitzer M, Paulsen F et al. (2004) The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancer. Nucl Med Commun 9: 90-97
14. Sanz G, Rioja J, Zudaire JJ et al. (2004) PET and prostate cancer. World J Urol 22: 351-352
15. Antoch G, Vogt FM, Freudenberg LS et al. (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290: 3199-3206
16. Schaefer JF, Fischmann A, Lichy M et al. (2004) Oncologic screening with whole-body MRI: possibilities and limitations. Radiologe 9: 854-863
17. Antoch G, Vogt FM, Bockisch A, Ruehm SG (2004) Whole-body tumor staging: MRI or FDG-PET/CT? Radiologe 9: 882-888
18. Daldrup-Link HE, Franzius C, Link TM et al. (2001) Whole-body MRI imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177: 229-236
19. Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A (2005) Whole-body MR imaging of bone marrow. Eur J Radiol 55: 33-40
20. Pfannenberg A, Oechsle K, Bokemeyer C et al. (2004) The role of [18F] FDG-PET, CT/MRI and tumor marker kinetics in the evaluation of postchemotherapy residual masses in metastatic germ cell tumors-prospects for management. World J Urol 22: 132-139
21. Pieterman RM, van Putten JW, Meuzelaar JJ et al. (2000) Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343: 254-261
22. Harisinghani MG, Barentz J, Hahn PF et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348: 2491-2499
23. Michel SC, Keller TM, Frohlich JM et al. (2002) Preoperative breast cancer staging: MR imaging of the axilla with utrasmall superparamgnetic iron oxide enhancement. Radiology 225: 527-536
24. Franzius C, Daldrup-Link HE, Wagner-Bohn A et al. (2002) FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 13: 157-160
25. Ghanem N, Kelly T, Altehoefer C et al. (2004) Ganzkörper MRT vs. Skelettszintigraphie bei der Detektion ossärer Metastasen solider Tumoren. Radiologe 44: 864-873
26. Ghanem N, Uhl M, Brink I et al. (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55: 41-55
27. AWMF online (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften). (07/200)
28. Johnston C, Brennan S, Ford S, Eustace S (2006) Whole body MR imaging: applications in oncology. Eur J Surg Oncol 32: 239-246
29. Krebs in Deutschland (2007) AG bevölkerungsbezogener Krebsregister in Deutschland, 4. Ausgabe, Saarbrücken; http://www.rki.de/KREBS
30. Plathow C (2004) Teleradiologie in der diagnostischen und klinischen Radiologie - Grundlagen, aktueller Stand und betriebswirtschaftliche Aspekte in Deutschland. Masterarbeit im Studiengang Humanmedizin mit betriebswirtschaftlicher Qualifikation der Ruprecht-Karls-Universität Heidelberg. Betriebswirtschaftliche Fakultät, Mannheim
31. Beinfeld MT, Wittenberg E, Gazelle GS (2005) Cost-effectiveness of whole body CT screening. Radiology 234: 415-422
32. Goyen M, Debatin JF (2005) Elective full-body screening examinations: a plea for MRI. World Hosp Health Serv 41: 32-34, 40, 42
33. Beinfeld MT, Gazelle GS (2005) Diagnostic imaging costs: are they driving up the costs of hospital care? Radiology 235: 934-939
34. Casarella WJ (2002) A patient's viewpoint on a current controversy. Radiology 224: 927
35. Jager GJ, Severens JL, Thornbury JR et al. (2000) Prostate cancer staging: should MR imaging be used? A decision analytic approach. Radiology 215: 445-451
36. Plathow C, Walz M, Engelmann U et al. (2005) Teleradiology: Economic analysis of CT investigations of a small hospital. Rofo 177: 1016-1026
37. Singer ME, Applegate KE (2001) Cost-effectiveness analysis in radiology. Radiology 219:611-620
38. Ladd SC, Zenge M, Antoch G, Forsting M (2006) Whole-body MR diagnostic concepts. Rofo 178: 763-770
39. Gutzeit A, Debatin JF, Antoch G (2004) Tumor staging with PET/CT. Detection of a second tumor. Rofo 176: 122-124
40. Pfannenberg C, Aschoff P, Schanz S et al. (2007) Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 43: 557-564
41. Müller-Horvat C*, Plathow C*, Ludescher B et al. (2007) (*equally contributed) Befunderstellung bei der Ganzkörperbildgebung mittels einer worflowoptimierten Befundungssoftware - Erste Erfahrungen einer Multireader Analyse. Rofo 179: 721-727